News Headlines

Display #
Diabetes control tied to heart stent outcomes
GSK must pay $3 million in generic Paxil suicide lawsuit: U.S. jury
GSK’s Advair faces first direct competition
Vernalis: FDA Issues CRL on CCP-07 NDA
When liver immune cells turn bad
WHO urges action over growing hepatitis epidemic
Valeant prices psoriasis treatment at $3,500 per month
2017 Manny Awards Winners Revealed
Novartis expands development programs for NASH through clinical collaboration with Allergan
Hanmi Pharma Charged for Failure to Report Patient Death in Olmutinib Study
J&J first-quarter 2017 revenue misses estimates
UnitedHealth plans for costly Obamacare tax in 2018
Allergan, Argentum settle patent dispute over eye drug Restasis
Oral contraceptives reduce general well-being in healthy women
Fungi have enormous potential for new antibiotics
Kowa Pharmaceuticals America Announces INTREPID Trial Results in The Lancet HIV Showing Superior LDL Cholesterol Reduction with LIVALO Compared with Pravastatin in Adults with HIV and Dyslipidemia
Gates backs push to wipe out tropical diseases
Verily launches study to track health data
As AstraZeneca chases rivals, immuno-oncology gets complicated
Pfizer receives subpoenas in U.S. intravenous saline solution probe
Abbott sees Alere as challenging ‘fixer-upper’ after revised deal
Scientists discover how a decades-old drug reduces the size of a heart attack
Hemophilia drug: positive results with children
Perrigo Shakes Up Exec Roster and Board, Hands Out a Fistful of Pink Slips
OncoMed Lung Cancer Med Fails Phase II
Bristol-Myers Squibb and Nordic Bioscience Announce Collaboration for Fibrosis Biomarker Technology
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine
Puma Biotechnology Announces FDA Advisory Committee to Review Neratinib for the Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer
Amarantus Forms Subsidiaries “Elto Pharma” to Focus on CNS Disorders and “MANF Therapeutics” to Focus on Ophthalmology
Trump signs resolution allowing U.S. states to block family planning funds